The Association Between Sedentary Behaviour and Cardiometabolic Health in Trained Athletes (HPAC)

March 14, 2022 updated by: Bert Op't Eijnde, Hasselt University

Do Trained Athletes Also Suffer From the Sedentary Behaviour Paradigm?: the Association Between Sedentary Behaviour and Cardiometabolic Health

Physical inactivity is one of the major contributing factors for the development of chronic diseases and highly correlated with increased all-cause mortality. In the last decade an exponential growth in research concerned with the study of sedentary behaviour and the potential for detrimental effects on health have been published. In this field increasing evidence suggests that prolonged periods of sedentary time, independent of the amount of physical activity, also increases the risk for the development of several chronic conditions and all-cause mortality. Here, sedentary behaviour is defined as "any waking behaviour, characterized by a low energy expenditure (≤1.5 METs), while being in a sitting or reclining posture". Interestingly, the advised moderate-to-vigorous bouts of exercise recommended by the various guidelines cannot compensate the negative impact on health risks arising from prolonged periods of sitting. In other words, it seems that people compensate their total amount of physical activity after exercise training by decreasing their physical activity levels throughout the rest of the day. Here, it appears that frequent, even low-intensity interruptions of periods of sitting are required for good cardiometabolic health. Therefore, not only physical activity but also prolonged sitting should be targeted to optimize cardiometabolic health. Nevertheless, a recent harmonized meta-syntheses indicated that the association between self-reported sitting with all-cause and cardiovascular disease mortality are only partially independent of physical activity, but were particularly evident in those who undertake insufficient physical activity (<150min/week). However, it is unclear whether high amounts of objectively measured physical activity attenuates or even eliminates the detrimental effects of prolonged sitting. In addition, it is still unclear whether high amounts of physical activity can preserve a healthy cardiometabolic risk profile, despite prolonged sitting. Therefore, in this study we want to investigate the association between sedentary behaviour, physical activity and cardiometabolic health in highly physically active adults.

Study Overview

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Diepenbeek, Limburg, Belgium, 3590
        • Wouter Franssen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Active individuals with at least 4 training hours per week and between 18 and 45 years of age.

Description

Inclusion Criteria:

  • Active individuals with at least 4 training hours per week

Exclusion Criteria:

  • pregnancy
  • Any known contradiction for physical activity
  • Systolic blood pressure >160mmHg, diastolic blood pressure >100mmHg
  • More than 20 alcohol consumptions per week
  • Participants diagnosed with any known chronic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Trained athletes
Active individuals with at least 4 training hours per week.
Athletes with a high physical activity and a low or high sedentary time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sedentary time (min/day)
Time Frame: day 1
Main outcome parameter of sedentary behaviour indication measured with ActivPAL3
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moderate-to-vigorous physical activity time (min/day)
Time Frame: day 1
Physical activity parameter measured with ActivPAL3
day 1
Light physical activity time (min/day)
Time Frame: day 1
Physical activity parameter measured with ActivPAL3
day 1
Blood glucose concentration
Time Frame: day 1
Parameter of glucose homeostatis
day 1
Blood insulin concentration
Time Frame: day1
Parameter of glucose homeostatis
day1
Blood total cholesterol concentration
Time Frame: day 1
Parameter of lipid metabolism
day 1
Blood triglyceride concentration
Time Frame: day 1
Parameter of lipid metabolism
day 1
Blood high density lipoprotein concentration
Time Frame: day 1
Parameter of lipid metabolism
day 1
Blood low density lipoprotein concentration
Time Frame: day 1
Parameter of lipid metabolism
day 1
Fat mass (kg)
Time Frame: day 1
Parameter of body composition measured with DEXA-scan
day 1
Lean mass (kg)
Time Frame: day 1
Parameter of body composition measured with DEXA-scan
day 1
Systolic blood pressure
Time Frame: day 1
Parameter of cardiovascular health
day 1
Diastolic blood pressure
Time Frame: day 1
Parameter of cardiovascular health
day 1
Maximal oxygen uptake
Time Frame: day 1
Parameter of oxygen capacity measured with cardiopulmonary exercise testing
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 10, 2021

Primary Completion (ACTUAL)

August 1, 2021

Study Completion (ACTUAL)

October 1, 2021

Study Registration Dates

First Submitted

January 13, 2021

First Submitted That Met QC Criteria

January 14, 2021

First Posted (ACTUAL)

January 15, 2021

Study Record Updates

Last Update Posted (ACTUAL)

March 15, 2022

Last Update Submitted That Met QC Criteria

March 14, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CME2020/012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Physical activity and sedentary behaviour

3
Subscribe